Dickkopf homolog 3 (DKK3): A candidate for detection and treatment of cancers?

J Cell Physiol

Biotechnology Research Center, Mashhad University of Medical Sciences, Pharmaceutical Technology Institute, Mashhad, Iran.

Published: June 2018

Wnt signaling is an evolutionary highly conserved pathway that is modulated by several inhibitors and activators, and plays a key role in numerous physiological processes. One of the extracellular Wnt inhibitors is the DKK (Dickkopf Homolog) family which has four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). DKK3 is a divergent member of the DKK protein family. Evidence suggests that DKK3 may serve as a potential therapeutic target in several types of human cancers. We review here the biological role of DKK3 as a tumor suppressor gene (TSG) or oncogene, and its correlation with various miRNAs. In addition, we discuss the role of polymorphisms and promoter methylation of the DKK3 gene, and of its expression in regulating cancer cell proliferation. Finally, we propose that DKK3 may be considered as both a biomarker and a therapeutic target in different cancers.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.26313DOI Listing

Publication Analysis

Top Keywords

dickkopf homolog
8
therapeutic target
8
dkk3
6
homolog dkk3
4
dkk3 candidate
4
candidate detection
4
detection treatment
4
treatment cancers?
4
cancers? wnt
4
wnt signaling
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!